Kohlberg Kravis Roberts & Co’s HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 HPX.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-10,672
Closed -$1K 240
2022
Q2
$1K Hold
10,672
﹤0.01% 258
2022
Q1
$2K Hold
10,672
﹤0.01% 273
2021
Q4
$6K Hold
10,672
﹤0.01% 203
2021
Q3
$7K Buy
+10,672
New +$7.95K ﹤0.01% 180

Other funds holding HPX.WS

Kohlberg Kravis Roberts & Co's HPX.WS Position: Q3 2022 in Review

Kohlberg Kravis Roberts & Co sold out of HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (HPX.WS) in Q3 2022, closing a stake of 10,672 shares — an estimated $1K sold.

Kohlberg Kravis Roberts & Co first reported a position in HPX.WS in Q3 2021 and held it in 4 quarters. The position peaked at $7K in Q3 2021. 39 funds tracked by Wall St. Rank hold HPX.WS as of Q3 2022.

  • Kohlberg Kravis Roberts & Co reported no remaining HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2022 after selling out during the quarter.
  • Kohlberg Kravis Roberts & Co sold 10,672 HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2022, an estimated $1K.
  • Kohlberg Kravis Roberts & Co first reported a position in HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q3 2021 and held it in 4 quarters.
  • Kohlberg Kravis Roberts & Co's HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $7K in Q3 2021.
  • 39 funds tracked by Wall St. Rank held HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2022.

Based on Kohlberg Kravis Roberts & Co's 13F filing for Q3 2022, filed 14 Nov 2022.